New heart Drug's effect on blood flow under the microscope
NCT ID NCT06599229
First seen Apr 16, 2026 · Last updated Apr 29, 2026 · Updated 1 time
Summary
This study looks at whether a new heart medication (cardiac myosin inhibitor) improves tiny blood vessel function in people with hypertrophic cardiomyopathy (HCM). Researchers will measure blood flow in the heart muscle using special ultrasound images. The study involves 30 adults with HCM who are already starting this therapy as part of their routine care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTROPHIC CARDIOMYOPATHY (HCM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Virginia
Charlottesville, Virginia, 22903, United States
Conditions
Explore the condition pages connected to this study.